Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
46M
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
6.28M
-
Shares change
-
+6.28M
-
Total reported value, excl. options
-
$13.5M
-
Value change
-
+$13.5M
-
Number of buys
-
25
-
Price
-
$2.15
Significant Holders of Theratechnologies Inc. - Common Shares (THTX) as of Q3 2023
26 filings reported holding THTX - Theratechnologies Inc. - Common Shares as of Q3 2023.
Theratechnologies Inc. - Common Shares (THTX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.28M shares
of 46M outstanding shares and own 13.66% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (2.33M shares), MORGAN STANLEY (2.26M shares), AIGH Capital Management LLC (803K shares), OSAIC HOLDINGS, INC. (225K shares), Worth Venture Partners, LLC (196K shares), Cyndeo Wealth Partners, LLC (104K shares), STIFEL FINANCIAL CORP (89.1K shares), NATIONAL BANK OF CANADA /FI/ (68.6K shares), Federation des caisses Desjardins du Quebec (49.7K shares), and Hamilton Capital, LLC (44.1K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.